A study for a 59 year old woman who takes Alphagan P, Wellbutrin - from FDA reports


Summary

24 females aged 59 (±5) who take the same drugs are studied. This is a personalized study for a 59 year old female patient who has Hyphema, Depression. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Oct, 11, 2017

24 females aged 59 (±5) who take Alphagan P, Wellbutrin are studied.


Number of reports submitted per year:

Alphagan P, Wellbutrin for a 59-year old woman.

Information of the patient in this study:

  • Age: 59
  • Gender: female
  • Conditions: Hyphema, Depression
  • Drugs taken:
    • Alphagan P (brimonidine tartrate)
    • Wellbutrin (bupropion hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • rashes
  • feeling hot
  • crying
  • skin blushing/flushing
  • emotional distress
  • rash papular
  • skin warm
  • dry skin
  • capillary fragility
  • rash macular
1 - 6 months:
  • nausea
  • headache
  • white blood cell count decreased
  • photopsia
  • neuralgia
  • red blood cell count decreased
  • high blood pressure
  • hyperhidrosis
  • nausea and vomiting
  • eye pain
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • nausea
  • headache
  • rashes
  • hyperhidrosis
  • sinusitis
  • eye pain
  • heart palpitations
  • neuralgia
  • weakness
  • dry eyes

Top conditions involved for these people *:

  • Rosacea (4 people, 16.67%)
  • Rheumatoid Arthritis (3 people, 12.50%)
  • Panic Disorder (3 people, 12.50%)
  • Hypothyroidism (3 people, 12.50%)
  • High Blood Pressure (3 people, 12.50%)

Top co-used drugs for these people *:

  • Zyrtec (7 people, 29.17%)
  • Tylenol (7 people, 29.17%)
  • Vitamin D (6 people, 25.00%)
  • Skelaxin (6 people, 25.00%)
  • Celebrex (6 people, 25.00%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Hyphema, Alphagan p, Depression, Wellbutrin

You may be interested in these reviews

More reviews for: Hyphema, Alphagan p, Depression, Wellbutrin